Unrecognized Tax Benefits of CASI Pharmaceuticals, Inc. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: CASI Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
CASI Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2024 was $558,000, a 41% decline year-over-year.
Source SEC data: View on sec.gov

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Change (%)

CASI Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$558,000	-$390,000	-41%	31 Dec 2024	20-F	31 Mar 2025	2024	FY
Q4 2023	$948,000	-$49,000	-4.9%	31 Dec 2023	20-F	31 Mar 2025	2024	FY
Q4 2022	$997,000	-$443,000	-31%	31 Dec 2022	20-F	31 Mar 2025	2024	FY
Q4 2021	$1,440,000	-$642,000	-31%	31 Dec 2021	20-F	31 Mar 2025	2024	FY
Q4 2020	$2,082,000	-$499,000	-19%	31 Dec 2020	20-F	28 Mar 2024	2023	FY
Q4 2019	$2,581,000			31 Dec 2019	20-F	26 Apr 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.